Bio
Dr. Bing Melody Zhang is board-certified by American Board of Pathology in Clinical Pathology and Molecular Genetic Pathology. She is also a certified and fully credentialed HLA laboratory director by American Society for Histocompatibility & Immunogenetics (ASHI) for the following areas--Solid Organ Transplantation: Deceased Donor; Solid Organ Transplantation: Live Donor; HSC/BM Transplantation: Related Donor; HSC/BM Transplantation: Unrelated Donor; Histocompatibility Testing for Other Clinical Purposes; Transfusion Support. Dr. Zhang completed Clinical Pathology residency, Molecular Genetic Pathology and Clinical Genomics fellowships, as well as Histocompatibility/Immunogenetics Director training at Stanford. She is currently the Director of the HLA lab (Stanford Blood Center) and Associate Section Director of the Molecular Pathology lab (Stanford Health Care). She also serves as the Chair of Molecular Pathology and Genomics Cluster (including CAP/ACMG Biochemical and Molecular Genetics Committee, CAP/ACMG Cytogenetics Committee, Molecular Oncology Committee, and Personalized Health Care Committee) of College of American Pathologists (CAP), Chair of CAP/ACMG Biochemical and Molecular Genetics Committee, and Chair of ASHI Science and Technology Initiatives Committee. Her main research interests include HLA testing for BMT/solid organ transplantation, NGS-based TCR/Ig clonality/MRD testing, HLA testing in cellular therapy and oncology, genetic/genomic testing for malignant and non-malignant hematologic disorders, and HLA-related disease association/drug hypersensitivity testing.
